Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Swedberg

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
The American Journal of Cardiology|May 1, 1983
Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarctionJ Herlitz, D Elmfeldt, A Hjalmarson, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Lancet (London, England)|October 17, 1981
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trialA Hjalmarson, D Elmfeldt, J Herlitz, et al.
The American Journal of Medicine|October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registryM R Shah, C B Granger, B A Bart, et al.
American Heart Journal|July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)R M Califf, K F Adams, W J McKenna, et al.
International Journal of Obesity (2005)|November 1, 2013
The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient dataR Padwal, F A McAlister, J J V McMurray, et al.
Lancet (London, England)|November 30, 2002
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international surveyJ G F Cleland, A Cohen-Solal, J Cosin Aguilar, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
European Journal of Heart Failure|June 17, 2000
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of YorkJ G Cleland, K Swedberg, A Cohen-Solal, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
The American Journal of Cardiology|May 1, 1983
Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarctionJ Herlitz, D Elmfeldt, A Hjalmarson, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Lancet (London, England)|October 17, 1981
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trialA Hjalmarson, D Elmfeldt, J Herlitz, et al.
The American Journal of Medicine|October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registryM R Shah, C B Granger, B A Bart, et al.
American Heart Journal|July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)R M Califf, K F Adams, W J McKenna, et al.
International Journal of Obesity (2005)|November 1, 2013
The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient dataR Padwal, F A McAlister, J J V McMurray, et al.
Lancet (London, England)|November 30, 2002
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international surveyJ G F Cleland, A Cohen-Solal, J Cosin Aguilar, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
European Journal of Heart Failure|June 17, 2000
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of YorkJ G Cleland, K Swedberg, A Cohen-Solal, et al.
Pageof 22